User profiles for J. Egido

Jesus Egido

- Verified email at fjd.es - Cited by 58044

Jose Egido

- Verified email at salud.madrid.org - Cited by 6587

TGF-β signaling in vascular fibrosis

…, E Sanchez-Lopez, G Carvajal, J Egido - Cardiovascular …, 2007 - academic.oup.com
… SL and J. RV are fellows of FIS. We would like to thank Melany van Oosram for the
careful reading of the manuscript. … N Engl J Med … Int J Mol Med …

Inflammation and angiotensin II

…, O Lorenzo, M Ruperez, V Esteban, J Egido - The international journal …, 2003 - Elsevier
Angiotensin II (AngII), the major effector peptide of renin–angiotensin system (RAS), is now
recognized as a growth factor that regulates cell growth and fibrosis, besides being a …

NF-κB in renal inflammation

…, B Santamaria, M Ruiz-Ortega, J Egido… - Journal of the …, 2010 - journals.lww.com
The NF-κB family of transcription factors regulates the induction and resolution of inflammation.
Two main pathways, classical and alternative, control the nuclear translocation of NF-κB. …

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in …

…, J Tunon, G Renedo, M Ruiz-Ortega, J Egido - Circulation, 1997 - Am Heart Assoc
Background The migration of monocytes into the vessel wall is a critical event leading to the
development of atherosclerosis. Monocyte chemoattractant protein-1 (MCP-1) is the main …

Quality of life among stroke survivors evaluated 1 year after stroke: experience of a stroke unit

J Carod-Artal, JA Egido, JL González… - Stroke, 2000 - Am Heart Assoc
Background and Purpose—We sought to study overall and domain-specific quality of life in
stroke survivors 1 year after stroke and to identify variables that could predict quality of life …

[HTML][HTML] Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes

…, E Calvo, O Sanchez-Pernaute, J Egido… - Osteoarthritis and …, 2003 - Elsevier
Objective: Glucosamine sulfate (GS) is a commonly used drug for the treatment of osteoarthritis.
The mechanism of the action of this drug does, however, remain to be elucidated. In …

[HTML][HTML] Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney

…, V Esteban, J Blanco, S Mezzano, J Egido - Kidney International, 2002 - Elsevier
… overlay panel Marta Ruiz-Ortega , Mónica Ruperez , Oscar Lorenzo, Vanesa Esteban , Julia
Blanco , Sergio Mezzano , Jesus EgidoJ Am Soc Nephrol, 3 (1993), pp. 1531-1540 … Egido

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

…, F Pérez, C Díaz, G Hernández, J Egido - Journal of the American …, 1998 - jacc.org
Objectives. To study the effect of the 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA)-reductase
inhibitor atorvastatin on the potential mechanisms involved in the recruitment of …

Biochemical and functional characterization of the interaction between pentraxin 3 and C1q

…, S Tzima, F Vivanco, J Egido… - European journal of …, 2003 - Wiley Online Library
Pentraxin 3 (PTX3) is a recently characterized member of the pentraxin family of acute‐phase
proteins produced during inflammation. Classical short pentraxins, C‐reactive protein, and …

[HTML][HTML] Transcription factor-κB (NF-κB) and renal disease

C Guijarro, J Egido - Kidney international, 2001 - Elsevier
… Moreover, preliminary data from our laboratory (Mezzano and Egido, personal communication)
have also confirmed the presence of activated NF-κB (Southwestern histochemistry) and …